Clinical Trial Update: A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial updating long-term use of alprazolam extended-release in adolescents with panic disorder; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• ALPRAZOLAM EXTENDED RELEASE (alprazolam)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Panic Disorder | Phase 4 | Status: TERMINATED